{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T22:20:47Z","timestamp":1793744447374,"version":"4.6.1"},"reference-count":27,"publisher":"Oxford University Press (OUP)","issue":"1","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,1,6]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Objectives<\/jats:title>\n                    <jats:p>Thymectomy reportedly increases the risk of cancer, autoimmune disease, and death. Studies are few and data limited. We sought to determine the incidence of postoperative malignancy and autoimmune disease in patients who underwent thymectomy.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We conducted a retrospective review of adult patients undergoing thymectomy between 2008 and 2020. Postoperative cancers and autoimmune disease were diagnosed after thymectomy. Incidence rates were calculated using patient-years and compared to the National Cancer Institute\u2019s (NCI) Surveillance, Epidemiology, and End Results (SEER) programme incidence of cancer for the US general population. Autoimmune disease rates were compared to previously published results.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>There were 226 patients with a median age of 55 years (interquartile range [IQR]\u2009=\u200939-67), mostly female (129, 57%) and non-smokers (132, 58%). At baseline, 117 (52%) had autoimmune disease, including 102 (45%) with myasthenia gravis. Eighty-four (37%) thymomas were identified. Median follow-up was 6.0 years (134 with &amp;gt;5-year follow-up and 44 with &amp;gt;10-year follow-up). We observed 13 (6%) new malignancies for an incidence of 0.87 cases\/100 person-years (0.87%) and comparable to the NCI rate of 0.81 cases\/100 person-years (0.81%). Incident cancers developed within the first 5 years after surgery at 0.92 cases\/100 person-years (0.92%) or 4.6% cumulatively over 5 years, compared to NCI data at 4%. There were 19 (8%) new autoimmune diagnoses with an incidence rate of 1.3 cases\/100 person-years (1.3%) and is higher than large population studies (0.7 cases\/100 person-years for all ages).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Development of new cancers following thymectomy in the United States is similar to the general population. But we identified a higher incidence of autoimmune disease, matching prior studies.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/ejcts\/ezag018","type":"journal-article","created":{"date-parts":[[2026,1,6]],"date-time":"2026-01-06T12:29:39Z","timestamp":1767702579000},"source":"Crossref","is-referenced-by-count":2,"title":["The Incidence of Malignancy and Autoimmune Disorders After Thymectomy: An Exploratory Study"],"prefix":"10.1093","volume":"68","author":[{"given":"Chloe E","family":"Hanson","sequence":"first","affiliation":[{"name":"Division of Thoracic Surgery, Swedish Medical Center , Seattle, WA 98104,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter T","family":"White","sequence":"additional","affiliation":[{"name":"Division of Thoracic Surgery, Swedish Medical Center , Seattle, WA 98104,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adam J","family":"Bograd","sequence":"additional","affiliation":[{"name":"Division of Thoracic Surgery, Swedish Medical Center , Seattle, WA 98104,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emily M","family":"Mackay","sequence":"additional","affiliation":[{"name":"Division of Thoracic Surgery, Swedish Medical Center , Seattle, WA 98104,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander S","family":"Farivar","sequence":"additional","affiliation":[{"name":"Division of Thoracic Surgery, Swedish Medical Center , Seattle, WA 98104,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric","family":"Valli\u00e8res","sequence":"additional","affiliation":[{"name":"Division of Thoracic Surgery, Swedish Medical Center , Seattle, WA 98104,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7599-1000","authenticated-orcid":false,"given":"Brian E","family":"Louie","sequence":"additional","affiliation":[{"name":"Division of Thoracic Surgery, Swedish Medical Center , Seattle, WA 98104,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2026,1,7]]},"reference":[{"key":"2026012303375864700_ezag018-B1","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/j.thorsurg.2018.12.001","article-title":"The role of the thymus in the immune response","volume":"29","author":"Thapa","year":"2019","journal-title":"Thorac Surg Clin"},{"key":"2026012303375864700_ezag018-B2","doi-asserted-by":"publisher","first-page":"e209482","DOI":"10.1212\/WNL.0000000000209482","article-title":"Does surgical removal of the thymus have deleterious consequences?","volume":"102","author":"Kaminski","year":"2024","journal-title":"Neurology"},{"key":"2026012303375864700_ezag018-B3","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1038\/s41577-023-00911-8","article-title":"A guide to thymic selection of T cells","volume":"24","author":"Ashby","year":"2024","journal-title":"Nat Rev Immunol"},{"key":"2026012303375864700_ezag018-B4","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1016\/j.it.2009.04.003","article-title":"Thymic involution and immune reconstitution","volume":"30","author":"Lynch","year":"2009","journal-title":"Trends Immunol"},{"key":"2026012303375864700_ezag018-B5","doi-asserted-by":"publisher","first-page":"S260","DOI":"10.1097\/JTO.0b013e3181f1f62d","article-title":"Epidemiology of thymoma and associated malignancies","volume":"5","author":"Engels","year":"2010","journal-title":"J Thorac Oncol"},{"key":"2026012303375864700_ezag018-B6","doi-asserted-by":"publisher","first-page":"1883","DOI":"10.1073\/pnas.1714478115","article-title":"Thymic involution and rising disease incidence with age","volume":"115","author":"Palmer","year":"2018","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2026012303375864700_ezag018-B7","doi-asserted-by":"publisher","first-page":"911","DOI":"10.1097\/jto.0b013e3181a4b8e0","article-title":"The management of thymoma: a systematic review and practice guideline","volume":"4","author":"Falkson","year":"2009","journal-title":"J Thorac Oncol"},{"key":"2026012303375864700_ezag018-B8","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1212\/WNL.0000000000011124","article-title":"International consensus guidance for management of myasthenia gravis: 2020 update","volume":"96","author":"Narayanaswami","year":"2021","journal-title":"Neurology"},{"key":"2026012303375864700_ezag018-B9","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1056\/NEJMoa2302892","article-title":"Health consequences of thymus removal in adults","volume":"389","author":"Kooshesh","year":"2023","journal-title":"N Engl J Med"},{"key":"2026012303375864700_ezag018-B10","doi-asserted-by":"publisher","first-page":"1072","DOI":"10.1002\/acn3.51055","article-title":"Risk of incident autoimmune diseases in patients with thymectomy","volume":"7","author":"Lin","year":"2020","journal-title":"Ann Clin Transl Neurol"},{"key":"2026012303375864700_ezag018-B11","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1016\/j.jtcvs.2024.09.004","article-title":"Does thymectomy in adults have long-term health consequences?","volume":"169","author":"Detterbeck","year":"2025","journal-title":"J Thorac Cardiovasc Surg"},{"key":"2026012303375864700_ezag018-B12","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1016\/0021-9681(87)90171-8","article-title":"A new method of classifying prognostic comorbidity in longitudinal studies: development and validation","volume":"40","author":"Charlson","year":"1987","journal-title":"J Chronic Dis"},{"key":"2026012303375864700_ezag018-B13","author":"Autoimmune Association","year":"2025"},{"key":"2026012303375864700_ezag018-B14","author":"National Cancer Institute","year":"2025"},{"key":"2026012303375864700_ezag018-B15","author":"National Cancer Institute","year":"2025"},{"key":"2026012303375864700_ezag018-B16","doi-asserted-by":"publisher","first-page":"1878","DOI":"10.1016\/S0140-6736(23)00457-9","article-title":"Incidence, prevalence, and co-occurrence of autoimmune disorders over time and by age, sex, and socioeconomic status: a population-based cohort study of 22 million individuals in the UK","volume":"401","author":"Conrad","year":"2023","journal-title":"Lancet"},{"key":"2026012303375864700_ezag018-B17","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1016\/1010-7940(94)90155-4","article-title":"Thymectomy and malignancy","volume":"8","author":"Masaoka","year":"1994","journal-title":"Eur J Cardiothorac Surg"},{"key":"2026012303375864700_ezag018-B18","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1007\/978-3-642-71076-6_32","volume-title":"Surgery of the Thymus: Pathology, Associated Disorders and Surgical Technique","author":"Papatestas","year":"1990"},{"key":"2026012303375864700_ezag018-B19","doi-asserted-by":"publisher","first-page":"1504496","DOI":"10.3389\/fimmu.2025.1504496","article-title":"Survival and autoimmune risks post-thymectomy","volume":"16","author":"Tsirkin","year":"2025","journal-title":"Front Immunol"},{"key":"2026012303375864700_ezag018-B20","doi-asserted-by":"publisher","first-page":"2808","DOI":"10.4049\/jimmunol.166.4.2808","article-title":"Effect of thymectomy on human peripheral blood T cell pools in myasthenia gravis","volume":"166","author":"Sempowski","year":"2001","journal-title":"J Immunol"},{"key":"2026012303375864700_ezag018-B21","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1016\/j.jtcvs.2019.11.052","article-title":"A systematic review of paraneoplastic syndromes associated with thymoma: treatment modalities, recurrence, and outcomes in resected cases","volume":"160","author":"Zhao","year":"2020","journal-title":"J Thorac Cardiovasc Surg"},{"key":"2026012303375864700_ezag018-B22","doi-asserted-by":"publisher","first-page":"1706","DOI":"10.1111\/ene.14730","article-title":"Cancer in myasthenia gravis subtypes in relation to immunosuppressive treatment and acetylcholine receptor antibodies: a Swedish nationwide register study","volume":"28","author":"Verwijst","year":"2021","journal-title":"Eur J Neurol"},{"key":"2026012303375864700_ezag018-B23","doi-asserted-by":"publisher","first-page":"e70143","DOI":"10.1002\/brb3.70143","article-title":"The association between myasthenia gravis and higher extrathymic cancer risk","volume":"15","author":"Khateb","year":"2025","journal-title":"Brain Behav"},{"key":"2026012303375864700_ezag018-B24","doi-asserted-by":"publisher","first-page":"774780","DOI":"10.3389\/fimmu.2021.774780","article-title":"Early thymectomy is associated with long-term impairment of the immune system: a systematic review","volume":"12","author":"Cavalcanti","year":"2021","journal-title":"Front Immunol"},{"key":"2026012303375864700_ezag018-B25","doi-asserted-by":"publisher","first-page":"e0180385","DOI":"10.1371\/journal.pone.0180385","article-title":"Autoimmunity and allergy control in adults submitted to complete thymectomy early in infancy","volume":"12","author":"Silva","year":"2017","journal-title":"PLoS One"},{"key":"2026012303375864700_ezag018-B26","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1111\/1759-7714.14723","article-title":"Clinical characteristics of myasthenia gravis patients developing other autoimmune diseases after thymectomy: a single-center cohort","volume":"14","author":"Tian","year":"2023","journal-title":"Thorac Cancer"},{"key":"2026012303375864700_ezag018-B27","doi-asserted-by":"publisher","first-page":"102638","DOI":"10.1016\/j.autrev.2020.102638","article-title":"Comorbidity of autoimmune diseases: a visual presentation","volume":"19","author":"Eaton","year":"2020","journal-title":"Autoimmun Rev"}],"container-title":["European Journal of Cardio-Thoracic Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ejcts\/advance-article-pdf\/doi\/10.1093\/ejcts\/ezag018\/66285282\/ezag018.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ejcts\/article-pdf\/68\/1\/ezag018\/66285282\/ezag018.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ejcts\/article-pdf\/68\/1\/ezag018\/66285282\/ezag018.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,23]],"date-time":"2026-01-23T08:38:16Z","timestamp":1769157496000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ejcts\/article\/doi\/10.1093\/ejcts\/ezag018\/8415851"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":27,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1,6]]}},"URL":"https:\/\/doi.org\/10.1093\/ejcts\/ezag018","relation":{},"ISSN":["1010-7940","1873-734X"],"issn-type":[{"value":"1010-7940","type":"print"},{"value":"1873-734X","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,1]]},"published":{"date-parts":[[2026,1]]},"article-number":"ezag018"}}